Folgen
Melissa F. Adasme
Titel
Zitiert von
Zitiert von
Jahr
PLIP: fully automated protein–ligand interaction profiler
S Salentin, S Schreiber, VJ Haupt, MF Adasme, M Schroeder
Nucleic acids research 43 (W1), W443-W447, 2015
16982015
PLIP 2021: Expanding the scope of the protein–ligand interaction profiler to DNA and RNA
MF Adasme, KL Linnemann, SN Bolz, F Kaiser, S Salentin, VJ Haupt, ...
Nucleic acids research 49 (W1), W530-W534, 2021
8062021
Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs
D Parisi, MF Adasme, A Sveshnikova, SN Bolz, Y Moreau, M Schroeder
Computational and Structural Biotechnology Journal 18, 1043-1055, 2020
662020
From malaria to cancer: Computational drug repositioning of amodiaquine using PLIP interaction patterns
S Salentin, MF Adasme, JC Heinrich, VJ Haupt, S Daminelli, Y Zhang, ...
Scientific reports 7 (1), 11401, 2017
492017
The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods
B Zdrazil, E Felix, F Hunter, EJ Manners, J Blackshaw, S Corbett, ...
Nucleic acids research 52 (D1), D1180-D1192, 2024
432024
Structure-based drug repositioning: potential and limits
MF Adasme, D Parisi, A Sveshnikova, M Schroeder
Seminars in cancer biology 68, 192-198, 2021
322021
Toward an understanding of pan-assay interference compounds and promiscuity: a structural perspective on binding modes
SN Bolz, MF Adasme, M Schroeder
Journal of Chemical Information and Modeling 61 (5), 2248-2262, 2021
252021
Repositioned drugs for chagas disease unveiled via structure-based drug repositioning
MF Adasme, SN Bolz, L Adelmann, S Salentin, VJ Haupt, ...
International Journal of Molecular Sciences 21 (22), 8809, 2020
242020
Structure-based drug repositioning explains ibrutinib as VEGFR2 inhibitor
MF Adasme, D Parisi, K Van Belle, S Salentin, VJ Haupt, GS Jennings, ...
PLoS One 15 (5), e0233089, 2020
242020
Controlling distinct signaling states in cultured cancer cells provides a new platform for drug discovery
SW Poser, O Otto, C Arps-Forker, Y Ge, M Herbig, C Andree, ...
The FASEB Journal, 2019
82019
Decomposing compounds enables reconstruction of interaction fingerprints for structure-based drug screening
MF Adasme, SN Bolz, A Al-Fatlawi, M Schroeder
Journal of Cheminformatics 14 (1), 17, 2022
32022
Structure based drug repositioning by exploiting structural properties of drug's binding mode
MF Adasme
2021
6 th Advanced in silico Drug Design KFC/ADD Welcome
K Berka, P Polishchuk, T Langer, J Kirchmair, MF Adasme, J Blackshaw, ...
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–13